Literature DB >> 1963290

Inhibitory effects of quinolones on pro- and eucaryotic DNA topoisomerases I and II.

N J Moreau1, H Robaux, L Baron, X Tabary.   

Abstract

As a means of gaining information on the selectivity of quinolone antibacterial agents, we examined their effect on four topoisomerases, topoisomerases I and II purified from Escherichia coli and calf thymus. The inhibition of supercoiling and relaxation activities was monitored by using the classical gel electrophoresis assay. Eight quinolones were assayed by using the four enzymes. Gyrase was much more sensitive to quinolones than the other topoisomerases which can therefore be inhibited by moderate concentrations of certain quinolones. No good correlation was observed between the activity on gyrase and on the other enzymes, since the ratio varied from 15 to more than 8,500. On the contrary, there was a good correlation between early inhibition of DNA synthesis, inhibition of gyrase, and MICs.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1963290      PMCID: PMC171971          DOI: 10.1128/AAC.34.10.1955

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  34 in total

Review 1.  DNA topoisomerases: enzymes that control DNA conformation.

Authors:  H P Vosberg
Journal:  Curr Top Microbiol Immunol       Date:  1985       Impact factor: 4.291

Review 2.  DNA topoisomerases.

Authors:  J C Wang
Journal:  Annu Rev Biochem       Date:  1985       Impact factor: 23.643

Review 3.  Biology of bacterial deoxyribonucleic acid topoisomerases.

Authors:  K Drlica
Journal:  Microbiol Rev       Date:  1984-12

4.  DNA gyrase on the bacterial chromosome: possibility of two levels of action.

Authors:  K Drlica; E C Engle; S H Manes
Journal:  Proc Natl Acad Sci U S A       Date:  1980-11       Impact factor: 11.205

5.  Escherichia coli DNA gyrase.

Authors:  R Otter; N R Cozzarelli
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

6.  Purification and characterization of a type II DNA topoisomerase from bovine calf thymus.

Authors:  B D Halligan; K A Edwards; L F Liu
Journal:  J Biol Chem       Date:  1985-02-25       Impact factor: 5.157

7.  New structure-activity relationships of the quinolone antibacterials using the target enzyme. The development and application of a DNA gyrase assay.

Authors:  J M Domagala; L D Hanna; C L Heifetz; M P Hutt; T F Mich; J P Sanchez; M Solomon
Journal:  J Med Chem       Date:  1986-03       Impact factor: 7.446

8.  Quinolone antibiotics inhibit eucaryotic DNA polymerase alpha and beta, terminal deoxynucleotidyl transferase but not DNA ligase.

Authors:  R Rusquet; M Bonhommet; J C David
Journal:  Biochem Biophys Res Commun       Date:  1984-06-29       Impact factor: 3.575

9.  Fluoronaphthyridines and quinolones as antibacterial agents. 2. Synthesis and structure-activity relationships of new 1-tert-butyl 7-substituted derivatives.

Authors:  D Bouzard; P Di Cesare; M Essiz; J P Jacquet; J R Kiechel; P Remuzon; A Weber; T Oki; M Masuyoshi; R E Kessler
Journal:  J Med Chem       Date:  1990-05       Impact factor: 7.446

10.  Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I.

Authors:  Y H Hsiang; R Hertzberg; S Hecht; L F Liu
Journal:  J Biol Chem       Date:  1985-11-25       Impact factor: 5.157

View more
  20 in total

1.  Coral-mucus-associated Vibrio integrons in the Great Barrier Reef: genomic hotspots for environmental adaptation.

Authors:  Jeremy E Koenig; David G Bourne; Bruce Curtis; Marlena Dlutek; H W Stokes; W Ford Doolittle; Yan Boucher
Journal:  ISME J       Date:  2011-01-27       Impact factor: 10.302

2.  The effect of topoisomerase II inhibitors on the kinetoplast ultrastructure.

Authors:  Danielle P Cavalcanti; Stênio P Fragoso; Samuel Goldenberg; Wanderley de Souza; Maria Cristina M Motta
Journal:  Parasitol Res       Date:  2004-10-28       Impact factor: 2.289

Review 3.  DNA gyrase, topoisomerase IV, and the 4-quinolones.

Authors:  K Drlica; X Zhao
Journal:  Microbiol Mol Biol Rev       Date:  1997-09       Impact factor: 11.056

4.  Mechanism of action of sparfloxacin against and mechanism of resistance in gram-negative and gram-positive bacteria.

Authors:  L J Piddock; M Zhu
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

5.  Sequence analysis, purification, and study of inhibition by 4-quinolones of the DNA gyrase from Mycobacterium smegmatis.

Authors:  V Revel-Viravau; Q C Truong; N Moreau; V Jarlier; W Sougakoff
Journal:  Antimicrob Agents Chemother       Date:  1996-09       Impact factor: 5.191

Review 6.  New quinolones and gram-positive bacteria.

Authors:  L J Piddock
Journal:  Antimicrob Agents Chemother       Date:  1994-02       Impact factor: 5.191

7.  Comparison of inhibition of Escherichia coli topoisomerase IV by quinolones with DNA gyrase inhibition.

Authors:  K Hoshino; A Kitamura; I Morrissey; K Sato; J Kato; H Ikeda
Journal:  Antimicrob Agents Chemother       Date:  1994-11       Impact factor: 5.191

8.  A pyrimido[1,6-a]benzimidazole that enhances DNA cleavage mediated by eukaryotic topoisomerase II: a novel class of topoisomerase II-targeted drugs with cytotoxic potential.

Authors:  A H Corbett; P Guerry; P Pflieger; N Osheroff
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

9.  Relationships among antibacterial activity, inhibition of DNA gyrase, and intracellular accumulation of 11 fluoroquinolones.

Authors:  S Bazile; N Moreau; D Bouzard; M Essiz
Journal:  Antimicrob Agents Chemother       Date:  1992-12       Impact factor: 5.191

10.  Effects of novel fluoroquinolones on the catalytic activities of eukaryotic topoisomerase II: Influence of the C-8 fluorine group.

Authors:  M J Robinson; B A Martin; T D Gootz; P R McGuirk; N Osheroff
Journal:  Antimicrob Agents Chemother       Date:  1992-04       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.